HDVY made an announcement that they recently sent out a letter of gratitude and support to Congressman Edolphus Towns, Chairman of the House Committee on Oversight and Government Reform for holding a congressional hearing on “Prostate Cancer: New Questions About Screening and Treatment.”
“Congressman Towns’ public hearing is timely and appropriate, given the overwhelming data about the failures of the PSA for detecting clinically significant prostate cancer,” said Stephen D. Barnhill, Chairman and CEO of Health Discovery Corporation. “Given our pioneering work in molecular diagnostic testing for prostate cancer, Health Discovery Corporation naturally offered to Congressman Towns our gratitude, support and ourselves as a resource to him and his committee as he continues to explore this important issue,” said Dr. Barnhill.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter
About Health Discovery Corporation
Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
Please click here to read the full
disclaimer